Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
Interventions: DRUG: Letrozole
Sponsor: Institut fuer Frauengesundheit
Collaborators: Novartis|ClinSol